Kilele Health
Oakwood, US · Founded 2023 · Delaware corporation · 1 known investors
Kilele Health develops the SunVida platform, a continuous biochemical monitoring system built on aptamer sensor technology in a glucose-monitor-style device format that provides real-time and longitudinal molecular data such as phenylalanine levels. It targets chronic disease management use cases including PKU, GLP-1 therapy muscle-loss monitoring, diabetes, chronic kidney disease, and heart failure for patients and clinical care teams.
Founders & leadership
Investors · 1
Competitors · 3
by search overlapCompanies competing with Kilele Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$264.5K disclosed across 1 round · 2025
▶$264.5KraisedOct 2025 · 3 investors · BiotechnologyRule 506(b)
- Jason Charles HeikenfeldExecutive Officer, Director, Promoter
- Sven SchreiberExecutive Officer
- Andrew David CothrelExecutive Officer, Director, Promoter
- Brittany Nicole ArdeExecutive Officer
- Offering amount
- $2M
- Amount sold
- $264.5K
- Minimum investment
- $48K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2022 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Kilele Health do?
- Kilele Health develops the SunVida platform, a continuous biochemical monitoring system built on aptamer sensor technology in a glucose-monitor-style device format that provides real-time and longitudinal molecular data such as phenylalanine levels. It targets chronic disease management use cases including PKU, GLP-1 therapy muscle-loss monitoring, diabetes, chronic kidney disease, and heart failure for patients and clinical care teams.
- Who are Kilele Health's investors?
- Kilele Health's investors include JumpStart Equity.
- How much funding has Kilele Health raised?
- Kilele Health has disclosed $264.5K raised across 1 round.
- Where is Kilele Health headquartered?
- Kilele Health is headquartered in Oakwood, US.